Cyclin D1 overexpression in primary hypopharyngeal carcinomas

Cancer

Volumn 78, Issue 3, 1996, Pages 390-395

  Masuda, Muneyuki ^a   Hirakawa, Naoya ^a   Nakashima, Torahiko ^a   Kuratomi, Yuichiro ^a   Komiyama, Sohtaro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

cervical lymph node metastases; immunohistochemistry; MIB 1; multimodality treatment; prognostic factor

Indexed keywords

CISPLATIN; CYCLINE; FLUOROURACIL; MONOCLONAL ANTIBODY KI 67; PEPLEOMYCIN; RETINOL;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LABELING INDEX; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; CYCLINS; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0029994302     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960801)78:3<390::AID-CNCR2>3.0.CO;2-O     Document Type: Article

References (40)

1. Muller D, Million R, Lidereau R, Engelmann A, Bronner G, Flesch H, et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer 1994;2:113-20.
2. Williams ME, Gaffey MI, Weiss LM, Wilczynski SP, Schuuring E, Lavine PA. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1993;119:1238-43.
3. Callender T, El-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1(CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994;74:152-8.
4. Michalides R, Veelen NV, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
5. Gillet C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, et al. Amplification and Overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-7.
6. Zhang SU, Caamano J, Cooper F, Guo B, Klein-szanto AJP. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994;102:695-8.
7. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, et al. Amplification and Overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993;196:1010-6.
8. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, et al. Amplification and Overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994;54:3107-10.
9. Tsuruta H, Sakamoto H, Onda M, Terada M. Amplification and Overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas. Biochem Biophys Res Commun 1993;196:1529-36.
10. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995;146:1161-9.
11. Zukerberg LR, Yang WI, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphomas. Am J Clin Pathol 1995;103:756-60.
12. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. In: Osborn M, editor. Cancer biology. London: W B Saunders Scientific Publications, 1990:99-206.
13. Hermanek P, Sobin LH, editors. UICC TNM Classification of malignant tumors. 4th edition. 2nd revision. Berlin: Springer-Verlag, 1992.
14. Komiyama S, Hiroto I, Ryu S, Nakasima T, Kuwano M, Endo H. Synergistic combination therapy of 5-fluorouracil, Vitamin A and cobalt-60 radiation upon head and neck tumors. Oncology 1978;35:253-7.
15. Shi SR, Key ME, Kalra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39:741-8.
16. Munakata S, Hendricks JB. Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem 1993;41:1241-6.
17. Sasaki K, Matumura K, Tsuji T, Shinozaki F, Takahashi M. Relationship between labeling indicies of Ki-67 and BrdUrd in human malignant tumors. Cancer 1988;62:989-93.
18. Gerdes J, Becker MHG, Key G, Gattoretti G. Immunohistochemical detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992;168:85-7.
19. Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, et al. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 1995;76:358-66.
20. Scotlandi K, Serra M, Manara MC, Maurici D, Benini S, Nini G, et al. Clinical relevance of Ki-67 expression in bone tumors. Cancer 1995;75:806-14.
21. Yamanaka N, Harubuchi Y, Kataura A. The prognostic value of Ki-67 antigen in non-Hodgikin lymphoma of Waldeyer's ring and the nasal cavity. Cancer 1992;70:2342-9.
22. Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S. Ki-67 immunostaining in human breast tumors and its relation to prognosis. Cancer 1991;67:421-8.
23. Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbs RR, Fazio VW. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma: a multivariate analysis. Cancer 1992;70:2602-9.
24. Cole DJ, Brown CD, Crossly E, Alcock CJ, Gatter KC. Carcinoma of the cervix uteri: an assessment of the relationship tumor proliferation to prognosis. Br J Cancer 1992;65:783-5.
25. Raymond WA, Leong AS-Y, Bolt JW, Milions J, Jose JS. Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining. J Pathol 1988;156:161-7.
26. Roland NJ, Caslin AW, Bowie GL, Jones AS. Has the cellular proliferation marker Ki-67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol 1994;19:13-8.
27. Nakano T, Oka K. Differential values of Ki-67 index and mitotic index of proliferating cell population. Cancer 1993;72:2401-8.
28. Tsuda T, Tahara E, Kajiyama G, Sakamoto H, Terada M, Sugimura T. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res 1989;49:5505-8.
29. Fantl V, Richards MA, Smith R, Lammie GA, Johnstone G, Allen D, et al. Gene amplification on chromosome band 11q13 and estrogen receptor status in breast cancer. Eur J Cancer 1990;26:423-9.
30. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, et al. PRAD1, a candidate BCLl oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991;88:9638-42.
31. Komatu H, Iida S, Yamamoto K, Mikuni C, Nitta M, Takahashi T, et al. A variant chromosome translocation at 11q13 identifying PRAD1/Cyclin D1 as the BCL-1 gene. Blood 1994;84:1226-31.
32. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991;350:512-5.
33. Inaba T, Matushime H, Valentine M, Roussel MF, Sherry CJ, Look AT. Genomic organization, chromosomal localization and independent expression of human cyclin D genes. Genomics 1992;13:565-74.
34. Xiong Y, Manninger J, Beach D, Ward DC. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 1992;13:575-84.
35. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992;71:505-14.
36. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1992;71:323-34.
37. Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14:2077-80.
38. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995;55:949-56.
39. Omura K, Misaki T, Watanabe Y, Urayama H, Hashimoto T, Matsu T. Reconstruction with free jejunal autograft after pharyngolaryngoesophagectomy. Ann Thorac Surg 1994;57: 117-8.
40. Ho CM, Lam KH, Wei WI, Yuen PW, Lam LK. Squamous cell carcinoma of the hypopharynx: analysis of treatment results. Head Neck 1993;15:405-12.